High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$818K
$818,246
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
APLS
S
Apellis Pharmaceuticals, Inc.
Watson David O.
• Officer • General Counsel
Sell to Cover
2026-01-22
$170,467
|
||||||
| APLS |
Apellis Pharmaceuticals, Inc.
|
Officer • General Counsel
Sell to Cover
|
2026-01-22 | $170,467 | S | Form 4 |
|
APLS
S
Apellis Pharmaceuticals, Inc.
Watson David O.
• Officer • General Counsel
Sell to Cover
2026-01-20
$48,987
|
||||||
| APLS |
Apellis Pharmaceuticals, Inc.
|
Officer • General Counsel
Sell to Cover
|
2026-01-20 | $48,987 | S | Form 4 |
|
APLS
S
Apellis Pharmaceuticals, Inc.
Watson David O.
• Officer • General Counsel
Sell to Cover
2026-01-13
$128,242
|
||||||
| APLS |
Apellis Pharmaceuticals, Inc.
|
Officer • General Counsel
Sell to Cover
|
2026-01-13 | $128,242 | S | Form 4 |
|
APLS
M
Apellis Pharmaceuticals, Inc.
Watson David O.
• Officer • General Counsel
Equity Compensation
2026-01-07
$13,276x2
|
||||||
| APLS |
Apellis Pharmaceuticals, Inc.
|
Officer • General Counsel
Equity Compensation
|
2026-01-07 | $13,276x2 | M | Form 4 |
|
APLS
S
Apellis Pharmaceuticals, Inc.
Watson David O.
• Officer • General Counsel
10b5-1 Sell
2025-12-16
$122,450
|
||||||
| APLS |
Apellis Pharmaceuticals, Inc.
|
Officer • General Counsel
10b5-1 Sell
|
2025-12-16 | $122,450 | S | Form 4 |
|
APLS
S
Apellis Pharmaceuticals, Inc.
Watson David O.
• Officer • General Counsel
10b5-1 Sell
2025-11-17
$100,300
|
||||||
| APLS |
Apellis Pharmaceuticals, Inc.
|
Officer • General Counsel
10b5-1 Sell
|
2025-11-17 | $100,300 | S | Form 4 |
|
APLS
S
Apellis Pharmaceuticals, Inc.
Watson David O.
• Officer • General Counsel
10b5-1 Sell
2025-10-16
$126,100
|
||||||
| APLS |
Apellis Pharmaceuticals, Inc.
|
Officer • General Counsel
10b5-1 Sell
|
2025-10-16 | $126,100 | S | Form 4 |
|
APLS
S
Apellis Pharmaceuticals, Inc.
Watson David O.
• Officer • General Counsel
10b5-1 Sell
2025-09-16
$121,700
|
||||||
| APLS |
Apellis Pharmaceuticals, Inc.
|
Officer • General Counsel
10b5-1 Sell
|
2025-09-16 | $121,700 | S | Form 4 |